AI assistant
Sending…
MEDIFAST INC — Director's Dealing 2021
Nov 15, 2021
33899_dirs_2021-11-15_2f6a98f6-c150-42db-8bb5-738973674619.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: MEDIFAST INC (MED)
CIK: 0000910329
Period of Report: 2021-11-11
Reporting Person: BYRNES KEVIN G (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2021-11-11 | Common Stock | M | 2917 | $26.52 | Acquired | 11071 | Direct |
| 2021-11-11 | Common Stock | M | 5000 | $31.55 | Acquired | 16071 | Direct |
| 2021-11-11 | Common Stock | M | 5000 | $27.68 | Acquired | 21071 | Direct |
| 2021-11-11 | Common Stock | F | 6149 | $228.45 | Disposed | 14922 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2021-11-11 | Stock Options | $26.52 | M | 2917 | Disposed | 2024-02-05 | Common Stock (2917) | Direct |
| 2021-11-11 | Stock Options | $31.55 | M | 5000 | Disposed | 2025-02-17 | Common Stock (5000) | Direct |
| 2021-11-11 | Stock Options | $27.68 | M | 5000 | Disposed | 2026-02-04 | Common Stock (5000) | Direct |
Footnotes
F1: Represents a withholding of 6,149 shares of the Issuer's common stock to satisfy the exercise price and the tax obligation in connection with the exercise of certain stock options.
F2: These options vested in three equal annual installments beginning on February 5, 2015.
F3: These options vested in three equal annual installments beginning on February 17, 2016.
F4: These options vested in three equal annual installments beginning on February 4, 2017.
More from MEDIFAST INC
Annual Report
2026
Apr 6
Director's Dealing
2026
Mar 27
Director's Dealing
2026
Mar 27
Director's Dealing
2026
Mar 27
Director's Dealing
2026
Mar 27
Major Shareholding Notification
2026
Mar 27
Major Shareholding Notification
2026
Mar 20
Regulatory Filings
2026
Mar 20
Annual Report
2026
Feb 17
Regulatory Filings
2026
Feb 17